Evidence map›Paper›PMID 21810307›Full record

Trial reportParasitology2011

Treatment with anthelminthics during pregnancy: what gains and what risks for the mother and child?

Alison M Elliott, Juliet Ndibazza, Harriet Mpairwe, Lawrence Muhangi, Emily L Webb, Dennison Kizito, Patrice Mawa, Robert Tweyongyere, Moses Muwanga, Entebbe Mother and Baby Study Team

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Parasitology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Praziquantel for the treatment of schistosomiasis during human pregnancy.Bulletin of the World Health Organization · 2018
    Trial
  4. Review
  5. Article
  6. Management ofIDCases · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. A Review on Strongyloidiasis in Pregnant Women.Research and reports in tropical medicine · 2021
    Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Alison M ElliottMRC/UVRI Uganda Research Unit on AIDS, Uganda Virus Research Institute, PO Box 49, Entebbe, Uganda. alison.tom@infocom.co.ug
Juliet Ndibazza
Harriet Mpairwe
Lawrence Muhangi
Emily L Webb
Dennison Kizito
Patrice Mawa
Robert Tweyongyere
Moses Muwanga
Entebbe Mother and Baby Study Team
Uganda Virus Research Institute · UGUniversity of London · GBMakerere University · UGMinistry of Agriculture, Animal Industry and Fisheries · UG

Funding

Medical Research Council G0700837Wellcome Trust 064693Wellcome Trust 074791Wellcome Trust 079110Wellcome Trust 095778
6 · The paper itself

Abstract

In 1994 and 2002, respectively, the World Health Organisation proposed that treatment for hookworm and schistosomiasis could be provided during pregnancy. It was hoped that this might have benefits for maternal anaemia, fetal growth and perinatal mortality; a beneficial effect on the infant response to immunisation was also hypothesised. Three trials have now been conducted. Two have examined the effects of benzimidazoles; one (the Entebbe Mother and Baby Study) the effects of albendazole and praziquantel. All three were conducted in settings of high prevalence but low intensity helminth infection. Results suggest that, in such settings and given adequate provision of haematinics, the benefit of routine anthelminthics during pregnancy for maternal anaemia may be small; none of the other expected benefits has yet been demonstrated. The Entebbe Mother and Baby Study found a significant adverse effect of albendazole on the incidence of infantile eczema in the whole study population, and of praziquantel on the incidence of eczema among infants of mothers with Schistosoma mansoni. Further studies are required in settings that differ in helminth species and infection intensities. Further research is required to determine whether increased rates of infantile eczema translate to long-term susceptibility to allergy, and to explore the underlying mechanisms of these effects. The risks and benefits of routine anthelminthic treatment in antenatal clinics may need to be reconsidered.

Indexed as

AlbendazoleAncylostomatoideaAnemiaAnimalsAnthelminticsBenzimidazolesBirth WeightChildDermatitis, AtopicDouble-Blind MethodFemaleHookworm InfectionsHumansInfantPerinatal MortalityPraziquantelAlbendazoleAnthelminticsbenzimidazoleBenzimidazolesPraziquantel

Identifiers

PMID21810307
PMCPMC3178871
OpenAlexW1994988691

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.